...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >l,8-Naphthalimide based DNA intercalators and anticancer agents. A?systematic review from 2007 to 2017
【24h】

l,8-Naphthalimide based DNA intercalators and anticancer agents. A?systematic review from 2007 to 2017

机译:L,8-萘酰亚胺基DNA嵌入剂和抗癌剂。 a?系统审查2007年至2017年

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In this review, we describe a detailed investigation about the structural variations and relative activity of 1,8-naphthalimide based intercalators and anticancer agents. The 1,8-naphthalimides binds to the DNA via intercalation, and exert their antitumor activities through Topoisomerase I/II inhibition, photoinduced DNA damage or related mechanism. Here, our discussion focused on works published over the last ten years (2007–2017) related to therapeutic applications, in the order of cancer treatment followed by other properties of 1,8-naphthalimides. In preparing for this review, we considered that several seminal reviews have appeared over the last fifteen years and focused on closely related subjects, however, none of them is exhaustive.
机译:在本文中,我们描述了关于基于1,8-萘酰亚胺基嵌入剂和抗癌剂的结构变异和相对活性的详细研究。 1,8-萘二烷酰胺通过嵌入与DNA结合,并通过拓扑异构酶I / II抑制,光导的DNA损伤或相关机制施加抗肿瘤活性。 在这里,我们的讨论侧重于在过去十年(2007 - 2017年)上发布的作品(2007 - 2017),其与治疗申请有关,癌症治疗顺序,其余特性为1,8-萘酰亚胺。 在准备这篇综述时,我们认为在过去十五年中出现了几个原创性评论,并专注于密切相关的科目,但是,他们都没有穷举。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号